Literature DB >> 29786069

VE-cadherin promotes vasculogenic mimicry by modulating kaiso-dependent gene expression.

Daniel Delgado-Bellido1,2, Mónica Fernández-Cortés1,2, María Isabel Rodríguez3, Santiago Serrano-Sáenz1,2, Arkaitz Carracedo2,4, Angel Garcia-Diaz5, F Javier Oliver6,7.   

Abstract

Aberrant extra-vascular expression of VE-cadherin (VEC) has been observed in metastasis associated with vasculogenic mimicry (VM); however, the ultimate reason why non-endothelial VEC favors the acquisition of this phenotype is not established. In this study, we show that human malignant melanoma cells have a constitutively high expression of phoshoVEC (pVEC) at Y658; pVEC is a target of focal adhesion kinase (FAK) and forms a complex with p120-catenin and the transcriptional repressor kaiso in the nucleus. FAK inhibition enabled kaiso to suppress the expression of its target genes and enhanced kaiso recruitment to KBS-containing promoters. Finally we have found that ablation of kaiso-repressed genes WNT11 and CCDN1 abolished VM. Thus, identification of pVEC as a component of the kaiso transcriptional complex establishes a molecular paradigm that links FAK-dependent phosphorylation of VEC as a major mechanism by which ectopical VEC expression exerts its function in VM.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29786069      PMCID: PMC6329820          DOI: 10.1038/s41418-018-0125-4

Source DB:  PubMed          Journal:  Cell Death Differ        ISSN: 1350-9047            Impact factor:   15.828


  41 in total

1.  The p120 catenin partner Kaiso is a DNA methylation-dependent transcriptional repressor.

Authors:  A Prokhortchouk; B Hendrich; H Jørgensen; A Ruzov; M Wilm; G Georgiev; A Bird; E Prokhortchouk
Journal:  Genes Dev       Date:  2001-07-01       Impact factor: 11.361

2.  VEGF-induced vascular permeability is mediated by FAK.

Authors:  Xiao Lei Chen; Ju-Ock Nam; Christine Jean; Christine Lawson; Colin T Walsh; Erik Goka; Ssang-Taek Lim; Alok Tomar; Isabelle Tancioni; Sean Uryu; Jun-Lin Guan; Lisette M Acevedo; Sara M Weis; David A Cheresh; David D Schlaepfer
Journal:  Dev Cell       Date:  2012-01-17       Impact factor: 12.270

3.  Finding the tumor copycat. Therapy fails, patients don't.

Authors:  Lee M Ellis; Isaiah J Fidler
Journal:  Nat Med       Date:  2010-09       Impact factor: 53.440

4.  Selective requirement for Src kinases during VEGF-induced angiogenesis and vascular permeability.

Authors:  B P Eliceiri; R Paul; P L Schwartzberg; J D Hood; J Leng; D A Cheresh
Journal:  Mol Cell       Date:  1999-12       Impact factor: 17.970

5.  Leukocyte extravasation and vascular permeability are each controlled in vivo by different tyrosine residues of VE-cadherin.

Authors:  Florian Wessel; Mark Winderlich; Maren Holm; Maike Frye; Ronmy Rivera-Galdos; Matthias Vockel; Ruth Linnepe; Ute Ipe; Anika Stadtmann; Alexander Zarbock; Astrid F Nottebaum; Dietmar Vestweber
Journal:  Nat Immunol       Date:  2014-02-09       Impact factor: 25.606

Review 6.  Vasculogenic mimicry and tumor angiogenesis.

Authors:  R Folberg; M J Hendrix; A J Maniotis
Journal:  Am J Pathol       Date:  2000-02       Impact factor: 4.307

7.  Gene alterations identified by expression profiling in tumor-associated endothelial cells from invasive ovarian carcinoma.

Authors:  Chunhua Lu; Tomas Bonome; Yang Li; Aparna A Kamat; Liz Y Han; Rosemarie Schmandt; Robert L Coleman; David M Gershenson; Robert B Jaffe; Michael J Birrer; Anil K Sood
Journal:  Cancer Res       Date:  2007-02-15       Impact factor: 12.701

8.  Vascular channel formation by human melanoma cells in vivo and in vitro: vasculogenic mimicry.

Authors:  A J Maniotis; R Folberg; A Hess; E A Seftor; L M Gardner; J Pe'er; J M Trent; P S Meltzer; M J Hendrix
Journal:  Am J Pathol       Date:  1999-09       Impact factor: 4.307

9.  DNA targeting specificity of RNA-guided Cas9 nucleases.

Authors:  Patrick D Hsu; David A Scott; Joshua A Weinstein; F Ann Ran; Silvana Konermann; Vineeta Agarwala; Yinqing Li; Eli J Fine; Xuebing Wu; Ophir Shalem; Thomas J Cradick; Luciano A Marraffini; Gang Bao; Feng Zhang
Journal:  Nat Biotechnol       Date:  2013-07-21       Impact factor: 54.908

10.  Inhibition of endothelial FAK activity prevents tumor metastasis by enhancing barrier function.

Authors:  Christine Jean; Xiao Lei Chen; Ju-Ock Nam; Isabelle Tancioni; Sean Uryu; Christine Lawson; Kristy K Ward; Colin T Walsh; Nichol L G Miller; Majid Ghassemian; Patric Turowski; Elisabetta Dejana; Sara Weis; David A Cheresh; David D Schlaepfer
Journal:  J Cell Biol       Date:  2014-01-20       Impact factor: 10.539

View more
  16 in total

Review 1.  The emerging roles of circular RNAs in vessel co-option and vasculogenic mimicry: clinical insights for anti-angiogenic therapy in cancers.

Authors:  Ying Shao; Bingjian Lu
Journal:  Cancer Metastasis Rev       Date:  2021-10-18       Impact factor: 9.264

2.  Co-immunoprecipitation of Protein Complexes from Different Subcellular Compartments in Vasculogenic Mimicry Studies.

Authors:  Daniel Delgado-Bellido; Angel Garcia-Diaz; Francisco Javier Oliver
Journal:  Methods Mol Biol       Date:  2022

3.  Inhibition of CD146 lessens uveal melanoma progression through reducing angiogenesis and vasculogenic mimicry.

Authors:  Ronghan Zhang; Xiaogang Chen; Shengwen Chen; Jiajia Tang; Feng Chen; Yong Lin; Peter Sol Reinach; Xiyun Yan; LiLi Tu; Hongxia Duan; Jia Qu; Qiang Hou
Journal:  Cell Oncol (Dordr)       Date:  2022-06-18       Impact factor: 7.051

Review 4.  Vascular mimicry: changing the therapeutic paradigms in cancer.

Authors:  Nazila Fathi Maroufi; Sina Taefehshokr; Mohammad-Reza Rashidi; Nima Taefehshokr; Mahdieh Khoshakhlagh; Alireza Isazadeh; Narmin Mokarizadeh; Behzad Baradaran; Mohammad Nouri
Journal:  Mol Biol Rep       Date:  2020-05-18       Impact factor: 2.316

5.  The Chk2-PKM2 axis promotes metabolic control of vasculogenic mimicry formation in p53-mutated triple-negative breast cancer.

Authors:  Pei Yu; Xiong Zhu; Jia-Le Zhu; Yu-Bao Han; Hao Zhang; Xiang Zhou; Lei Yang; Yuan-Zheng Xia; Chao Zhang; Ling-Yi Kong
Journal:  Oncogene       Date:  2021-07-09       Impact factor: 9.867

Review 6.  Molecular Mechanisms and Anticancer Therapeutic Strategies in Vasculogenic Mimicry.

Authors:  Xue Zhang; Jigang Zhang; Heming Zhou; Guorong Fan; Qin Li
Journal:  J Cancer       Date:  2019-10-18       Impact factor: 4.207

7.  The Angiotensin-Converting Enzyme Inhibitory State Promotes the Transformation of Non-Small Cell Lung Cancer Blood Supply Pattern Toward Vasculogenic Mimicry Formation.

Authors:  Kandi Xu; Huize Han; Yexin Luo; Hong Ye; Hongxia Lin; Lei Ni
Journal:  Front Oncol       Date:  2021-06-16       Impact factor: 6.244

8.  RNA m6A methylation promotes the formation of vasculogenic mimicry in hepatocellular carcinoma via Hippo pathway.

Authors:  Kailiang Qiao; Yantao Liu; Zheng Xu; Haohao Zhang; Heng Zhang; Chao Zhang; Zhi Chang; Xinyan Lu; Zhongwei Li; Ce Luo; Yanrong Liu; Cheng Yang; Tao Sun
Journal:  Angiogenesis       Date:  2020-09-13       Impact factor: 10.658

9.  Extracellular Protease ADAMTS1 Is Required at Early Stages of Human Uveal Melanoma Development by Inducing Stemness and Endothelial-Like Features on Tumor Cells.

Authors:  Carlos Peris-Torres; María Del Carmen Plaza-Calonge; Raúl López-Domínguez; Silvia Domínguez-García; Antonio Barrientos-Durán; Pedro Carmona-Sáez; Juan Carlos Rodríguez-Manzaneque
Journal:  Cancers (Basel)       Date:  2020-03-27       Impact factor: 6.639

Review 10.  Vasculogenic Mimicry: Become an Endothelial Cell "But Not So Much".

Authors:  Mónica Fernández-Cortés; Daniel Delgado-Bellido; F Javier Oliver
Journal:  Front Oncol       Date:  2019-08-22       Impact factor: 6.244

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.